Global Baculovirus Expression System Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Baculovirus Expression System Market Insights, Forecast to 2034
Baculovirus Expression System is a type of protein expression system that uses insect cells and baculoviruses to produce recombinant proteins. This system has become increasingly popular for the expression of eukaryotic proteins that are difficult to produce in other systems, such as bacteria or yeast. Baculovirus Expression System involves the insertion of a gene of interest into a baculovirus genome, which is then used to infect insect cells. The infected cells then produce large quantities of the recombinant protein, which can be purified and used for various applications, such as drug discovery, vaccine development, and protein structure analysis.
Market Analysis and InsightsGlobal Baculovirus Expression System Market
Global Baculovirus Expression System market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Baculovirus Expression System industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for Baculovirus Expression System has been witnessing steady growth due to its versatility, high expression levels, and post-translational modifications that closely resemble those in higher eukaryotes. The system finds applications in various fields, including biopharmaceuticals, research, and industrial biotechnology. The United States and Canada have a strong presence in the Baculovirus Expression System market, driven by a robust biopharmaceutical industry and significant investments in research and development. European countries have a prominent role in academic research and industrial applications of the Baculovirus Expression System, with a focus on producing high-value recombinant proteins. Asia-Pacific is experiencing growth in the Baculovirus Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Baculovirus Expression System market is expected to continue growing as biopharmaceutical companies seek efficient and reliable methods for producing complex proteins. Advances in gene editing technologies and the development of high-yield insect cell lines are likely to further enhance the capabilities of the system. Additionally, the increasing demand for biologics and personalized medicine is expected to drive the adoption of Baculovirus Expression System in the coming years.
Report Covers
This report presents an overview of global Baculovirus Expression System market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Baculovirus Expression System market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Expression Systems
Creative BioMart
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Autographa Californica Multiple Nucleopolyhedrovirus
Bombyx Mori Nucleopolyhedrovirus
Others
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Baculovirus Expression System introduction, etc. Baculovirus Expression System Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Baculovirus Expression System
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Baculovirus Expression System Market
Global Baculovirus Expression System market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Baculovirus Expression System industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global market for Baculovirus Expression System has been witnessing steady growth due to its versatility, high expression levels, and post-translational modifications that closely resemble those in higher eukaryotes. The system finds applications in various fields, including biopharmaceuticals, research, and industrial biotechnology. The United States and Canada have a strong presence in the Baculovirus Expression System market, driven by a robust biopharmaceutical industry and significant investments in research and development. European countries have a prominent role in academic research and industrial applications of the Baculovirus Expression System, with a focus on producing high-value recombinant proteins. Asia-Pacific is experiencing growth in the Baculovirus Expression System market, driven by increasing research activities, biopharmaceutical development, and the expansion of the industrial biotechnology sector. The Baculovirus Expression System market is expected to continue growing as biopharmaceutical companies seek efficient and reliable methods for producing complex proteins. Advances in gene editing technologies and the development of high-yield insect cell lines are likely to further enhance the capabilities of the system. Additionally, the increasing demand for biologics and personalized medicine is expected to drive the adoption of Baculovirus Expression System in the coming years.
Report Covers
This report presents an overview of global Baculovirus Expression System market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Baculovirus Expression System market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Expression Systems
Creative BioMart
Profacgen
Sino Biological
Hangzhou Clongene Biotech
Segment by Type
Autographa Californica Multiple Nucleopolyhedrovirus
Bombyx Mori Nucleopolyhedrovirus
Others
Segment by Application
Drugs Development
Biomedical Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Baculovirus Expression System introduction, etc. Baculovirus Expression System Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Baculovirus Expression System
Chapter 13Methodology and Data Sources adopted by MRAResearch